{"id":4863,"date":"2025-03-25T12:20:41","date_gmt":"2025-03-25T12:20:41","guid":{"rendered":"https:\/\/www.nordicbioscience.com\/?post_type=biomarker-solution&p=4863"},"modified":"2025-06-13T12:32:40","modified_gmt":"2025-06-13T12:32:40","slug":"neuroscience","status":"publish","type":"biomarker-solution","link":"https:\/\/www.nordicbioscience.com\/biomarker-solution\/neuroscience\/","title":{"rendered":"Neuroscience"},"content":{"rendered":"
\n
\n
\n

Biomarkers for Neuroscience<\/h1>\n

We are doing very interesting research on applicable biomarkers for neuroscience indications. Our most advanced research is on biomarkers for Alzheimer’s disease, where identifying active neurodegeneration is critical.<\/p>\n

\n \n Browse our neuroscience biomarkers \n \n <\/svg>\n \n <\/a>\n <\/div>\n <\/article>\n <\/div>\n<\/section>\n\n\n\n\n
\n \n
\n
\n
\n
\n

Biomarkers for Alzheimer’s disease<\/h2>\n \n\n <\/div>\n
\n

Neurodegenerative diseases are a broad collection of diseases,\u00a0which are all characterized by loss of neuronal function. That includes (but not limited to) Alzheimer’s disease, frontotemporal dementia, and Parkinson’s disease to which biomarkers will be described on the below page. One of the primary goals is to identify active neurodegeneration\u00a0and find out if treatment will halt or slow that process. Our biomarkers can do that.<\/p>\n <\/div>\n

\n

Publications<\/h3>\n